Independent health-science reporting · Evidence ratedEvidence rated
Independent health-science reporting
Beyond today’s standard of care.
Every story carries an evidence rating, named sources, and a plain account of what remains uncertain.
A retrospective study of a community-based program shows a significant drop in late-stage cases alongside signs of potential overdiagnosis.
A study tracking 25 years of publication data maps how the clinical and academic focus has transitioned toward neoadjuvant and combination strategies.
Post-treatment detection of circulating tumor DNA 2 years after chemotherapy is strongly associated with distant recurrence and poorer overall survival.
A retrospective study identifies age, sex, grip strength, and frailty as key predictors of cognitive changes after allogeneic transplantation.
Cancer Innovation
Treatment, resistance, and the science reshaping oncology.
5 stories
Precision Medicine
Matching treatment to biology, one patient at a time.
7 stories
Diagnostics
Detection, monitoring, and the limits of early testing.
1 story
Integrative & Supportive Care
Tolerability, recovery, and quality of life during treatment.
6 stories
Research & Trials
What is being studied, where, and what it would prove.
4 stories
Announcements, paid press releases, and sponsored features. This material is not produced by the NSH editorial desk.
No announcements or sponsored features have been approved for release yet.
All newsroom items →
